Entrada Therapeutics Reports First Quarter 2025 Financial Results
Go back to Entrada Therapeutics Reports First Quarter 2025 Financial Results| (NASDAQ: TRDA) | Delayed: 7.67 +0.63 (8.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.04 | 52 Week High | $ | |||
| Open | $7.03 | 52 Week Low | $ | |||
| Day High | $7.68 | P/E | N/A | |||
| Day Low | $6.93 | EPS | $ | |||
| Volume | 263,620 | |||||

